Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients

2021 ◽  
Author(s):  
Ronald Chow ◽  
Leonard Chiu ◽  
Jørn Herrstedt ◽  
Matti Aapro ◽  
Michael Lock ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Emetogenic Chemotherapy ◽  
Nausea And Vomiting ◽  
Antiemetic Therapy ◽  
Highly Emetogenic Chemotherapy ◽  
Effectiveness Analysis

Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery

1995 ◽  
Vol 7 (6) ◽  
pp. 551-552
Author(s):  
Alfred P.J. Lake ◽  
Stefan Hugo ◽  
Gert Coetzee ◽  
Beryl A. Cooledge
Keyword(s):  
Cost Effectiveness ◽  
Ambulatory Surgery ◽  
Cost Effectiveness Analysis ◽  
Antiemetic Therapy ◽  
Effectiveness Analysis

Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium

2007 ◽  
Vol 16 (8) ◽  
pp. 905-915 ◽  
Author(s):  
Lieven Annemans ◽  
Daniëlle Strens ◽  
Erica Lox ◽  
Christine Petit ◽  
Hughes Malonne
Keyword(s):  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Nausea And Vomiting ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document